SCHEMBL7258997

SCHEMBL7258997

CCS(=O)(=O)N(C)c1nc(C(=O)NCc2ccc(F)cc2C(=O)N(C)C)c(O)c2ncccc12

nearest known ligand 0.44

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 9/20 0.42
ADORA1 P30542 9/20 0.42
CALCA P06881 4/20 0.40
COMT P21964 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
HTR5A P47898 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766011 0.93 ADORA2A (0.42) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL4762100 0.93 ADORA2A (0.42) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL7258981 0.89 ADORA2A (0.41) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL7258671 0.86 ADORA2A (0.44) ADORA2AADORA1CALCAL3MBTL1EGLN1
SCHEMBL7262470 0.85 ADORA2A (0.42) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL7257940 0.85 ADORA2A (0.42) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL4763351 0.85 ADORA2A (0.45) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL4768982 0.85 ADORA2A (0.43) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL7262580 0.85 ADORA2A (0.42) ADORA2AADORA1CALCACOMTL3MBTL1
SCHEMBL4765511 0.83 ADORA2A (0.41) ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003077857-A2 N-(SUBSTITUTED BENZYL)-8-HYDROXY-1,6-NAPHTHYRIDINE-7- CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2003-09-25 WO claimed
WO-2003077857-A2 N-(SUBSTITUTED BENZYL)-8-HYDROXY-1,6-NAPHTHYRIDINE-7- CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2003-09-25 WO disclosed